BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26829054)

  • 1. Induction Therapy for Lung Transplantation in COPD: Analysis of the UNOS Registry.
    Duffy JS; Tumin D; Pope-Harman A; Whitson BA; Higgins RS; Hayes D
    COPD; 2016 Oct; 13(5):647-52. PubMed ID: 26829054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents.
    Whitson BA; Kilic A; Lehman A; Wehr A; Hasan A; Haas G; Hayes D; Sai-Sudhakar CB; Higgins RS
    Clin Transplant; 2015 Jan; 29(1):9-17. PubMed ID: 25284138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y; Jayarajan SN; Taghavi S; Cordova FC; Patel N; Shiose A; Leotta E; Criner GJ; Guy TS; Wheatley GH; Kaiser LR; Toyoda Y
    Am J Transplant; 2016 Aug; 16(8):2334-41. PubMed ID: 26833657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contemporary analysis of induction immunosuppression in pediatric lung transplant recipients.
    Hayes D; Kirkby S; Wehr AM; Lehman AM; McConnell PI; Galantowicz M; Higgins RS; Whitson BA
    Transpl Int; 2014 Feb; 27(2):211-8. PubMed ID: 24236829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival.
    Whitson BA; Lehman A; Wehr A; Hayes D; Kirkby S; Pope-Harman A; Kilic A; Higgins RS
    Clin Transplant; 2014 Apr; 28(4):450-61. PubMed ID: 24750290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
    Ansari D; Höglund P; Andersson B; Nilsson J
    J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
    Ansari D; Lund LH; Stehlik J; Andersson B; Höglund P; Edwards L; Nilsson J
    J Heart Lung Transplant; 2015 Oct; 34(10):1283-91. PubMed ID: 26087667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation.
    Hachem RR; Chakinala MM; Yusen RD; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2005 Sep; 24(9):1320-6. PubMed ID: 16143251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes with alemtuzumab induction after lung transplantation.
    Shyu S; Dew MA; Pilewski JM; DeVito Dabbs AJ; Zaldonis DB; Studer SM; Crespo MM; Toyoda Y; Bermudez CA; McCurry KR
    J Heart Lung Transplant; 2011 Jul; 30(7):743-54. PubMed ID: 21420318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
    Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of induction immunosuppression in cystic fibrosis lung transplant recipients.
    Kirkby S; Whitson BA; Wehr AM; Lehman AM; Higgins RS; Hayes D
    J Cyst Fibros; 2015 Jan; 14(1):104-10. PubMed ID: 24948447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy in lung transplantation: A contemporary analysis of trends and outcomes.
    Shagabayeva L; Osho AA; Moonsamy P; Mohan N; Li SS; Wolfe S; Langer NB; Funamoto M; Villavicencio MA
    Clin Transplant; 2022 Nov; 36(11):e14782. PubMed ID: 35848518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.
    Butts RJ; Dipchand AI; Sutcliffe D; Bano M; Dimas V; Morrow R; Das B; Kirk R
    Pediatr Transplant; 2018 Jun; 22(4):e13190. PubMed ID: 29878688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab induction in renal transplantation.
    Hanaway MJ; Woodle ES; Mulgaonkar S; Peddi VR; Kaufman DB; First MR; Croy R; Holman J;
    N Engl J Med; 2011 May; 364(20):1909-19. PubMed ID: 21591943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J; Terasaki PI
    Transplantation; 2010 Dec; 90(12):1511-5. PubMed ID: 21057388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis.
    Li KHC; Ho JCS; Recaldin B; Gong M; Ho J; Li G; Liu T; Wu WKK; Wong MCS; Xia Y; Dong M; Tse G;
    Transplant Proc; 2018 Dec; 50(10):3723-3731. PubMed ID: 30577263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients.
    Taber DJ; McGillicuddy JW; Bratton CF; Rohan VS; Nadig S; Dubay D; Baliga PK
    Ann Surg; 2017 Sep; 266(3):450-456. PubMed ID: 28654544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
    Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
    Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
    N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.